Latest round

Series A

Last raised

May 2025

Total raised

$42M

Investors

5

About SUNGEN

, trading under the name SUNGEN, develops large molecule biopharmaceuticals, including antibody drugs and early-stage biologic candidates. The company focuses on therapeutic areas such as oncology, autoimmune diseases, and cardiovascular conditions. SUNGEN collaborates with medical institutions and pharmaceutical companies involved in preclinical and clinical development., Ltd.6 million. The company works with pharmaceutical firms, healthcare providers and research institutions to develop antibody-based therapeutics, including First-In-Class antibodies and Antibody-Drug Conjugates. Its activities include early stage drug discovery, preclinical development and advancement of biologic candidates for multiple disease areas., Ltd.

Who invested in SUNGEN

5 investors across 1 round

See all investors in SUNGEN

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 29, 2025

    Amount

    $42M

    Investors

    Locked

Questions about SUNGEN

Who invested in SUNGEN?

SUNGEN has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SUNGEN raised?

SUNGEN has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did SUNGEN last raise money?

SUNGEN's most recent round on record is a Series A, in May 2025.

What does SUNGEN do?

, trading under the name SUNGEN, develops large molecule biopharmaceuticals, including antibody drugs and early-stage biologic candidates.

Where is SUNGEN headquartered?

SUNGEN is headquartered in Beijing, China.

Which VCs invest in companies like SUNGEN?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at SUNGEN's stage. Their profiles are linked below.

Raising like SUNGEN? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.